Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications

Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications

Aim. To study effects of thrombin-activated fibrinolysis inhibitor (TAFI) on efficacy and safety of long-term anti-coagulant treatment in patients with venous thromboembolic complications (VTEC). Material and methods. A total of 111 patients with a history of an episode of deep vein thrombosis (DVT)...

Full description

Bibliographic Details
Main Authors: Natal'ya Mikhaylovna Vorob'eva, Elizaveta Pavlovna Panchenko, Anatoliy Borisovich Dobrovol'skiy, Elena Vladimirovna Titaeva, O V Ermolina, T V Balakhonova, Zukhra Bilyalovna Khasanova, Anton Yuvenal'evich Postnov, Aleksandr Ivanovich Kirienko, N M Vorobyeva, E P Panchenko, A B Dobrovolsky, E V Titaeva, Z B Khasanova, A Yu Postnov, A I Kirienko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2011-12-01
Series:Терапевтический архив
Subjects:
thrombinactivated fibrinolysis inhibitor
deep vein thrombosis
recurrence
warfarin
hemorrhagic complications
thrombus lysis
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/30947

Internet

https://ter-arkhiv.ru/0040-3660/article/view/30947

Similar Items